Bacterial polysaccharides as vaccines--immunity and chemical characterization.
Studies on protective immunity and biochemical characterization of bacterial capsular polysaccharides have led to significant contributions to understanding of the mechanisms of infectious diseases and development of effective vaccines. Immunity to encapsulated bacteria is related to antibody response to polysaccharide (PS) antigen, interactions with T- and B-lymphocytes, and host defense mechanisms. Meningococcal, pneumococcal and Salmonella vi PSs and Haemophilus type b PS-protein conjugate vaccines have been licensed and provided effective immunity for prevention of these bacterial infections. Capsular PSs are cell-surface polymers consisting of oligosaccharide repeating units. Many PSs are highly polar and hydrophilic and interfere with cell-to-cell interactions with phagocytes. Most pneumococcal PSs are negatively charged and possess acidic components such as D-glucuronic acid and phosphate in phosphodiester bonds. Extensive immunologic cross-reactivity has been observed among bacterial capsular PSs. In infants the antibody responses to most capsular PSs are generally poor. Enhanced immunogenicity of PS antigens can be achieved through PS-protein conjugate vaccines, immunization during a critical period of perinatal development and effective antigen delivery system.
Lee
C J
CJ
Center for Biologics Evaluation and Research, FDA, Bethesda MD 20817, USA.
Lee
L H
LH
Lu
C S
CS
Wu
A
A
D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control; D001428:Bacterial Vaccines / Q000737:chemistry / Q000276:immunology*; D002240:Carbohydrate Sequence; D003429:Cross Reactions; D004926:Escherichia coli / Q000276:immunology; D006001:Glycoconjugates / Q000737:chemistry / Q000276:immunology; D019741:Haemophilus influenzae type b / Q000276:immunology; D006801:Humans; D007709:Klebsiella / Q000276:immunology; D008969:Molecular Sequence Data; D009345:Neisseria meningitidis / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000276:immunology*; D011549:Pseudomonas / Q000276:immunology; D012485:Salmonella typhi / Q000276:immunology; D013292:Streptococcus agalactiae / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology
D001428:Bacterial Vaccines; D006001:Glycoconjugates; D011135:Polysaccharides, Bacterial